The Use of Libre to Improve Metabolic Control and Reduce Reliance on Medication

NACompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

November 1, 2020

Primary Completion Date

August 1, 2021

Study Completion Date

September 1, 2021

Conditions
Diabetes Mellitus, Type 2
Interventions
BEHAVIORAL

GEM + CGM

Participants follow the GEM guidebook for 4 months (1 month of intervention and 3 months of maintenance) while wearing a FitBit activity monitor and a Freestyle Libre 2 CGM to provide feedback about activity and blood glucose. The GEM guidebook covers Routine choices, Recovering from blood glucose excursions, Reducing blood glucose excursions, and Maintenance.

Trial Locations (1)

22908

Dept. of Psychiatry and Neurobehavioral Sciences, University of Virginia, Charlottesville

All Listed Sponsors
collaborator

University of Colorado, Denver

OTHER

collaborator

West Virginia University

OTHER

lead

University of Virginia

OTHER

NCT04632849 - The Use of Libre to Improve Metabolic Control and Reduce Reliance on Medication | Biotech Hunter | Biotech Hunter